ArriVent BioPharma (AVBP) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.08
-0.92
-0.76
-0.6

Details

Expected EPS
-0.665095
Actual EPS
-0.6
Surprise EPS
0.07
Surprise Percent
+9.79%

Description

ArriVent BioPharma (AVBP) has reported earnings of -0.6 per share for Q1 2025.

0 Comments

Share your thoughts